De la Fuente López M and his research team have evaluated the levels of chemokines (CCL2, CCL3, CCL4, CCL5, and CX3CL1), TNF-α, and VEGF, in both plasma and tissue lysates of 48 CRC Chilean patients. This evidence concerns the gene VEGFA and colorectal carcinoma.